Lexicon Pharmaceuticals annual gross margin
2015
2017
2018
2019
2020
2023
2024
2025
Lexicon Pharmaceuticals Gross Margin Growth & History (LXRX)
Lexicon Pharmaceuticals's gross margin was 99.45% for fiscal 2025.
View full Lexicon Pharmaceuticals company overviewLexicon Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 99.45% | +9.71 pp |
| 2024 | 2024-12-31 | 89.74% | −2.61 pp |
| 2023 | 2023-12-31 | 92.34% | — |
| 2020 | 2020-12-31 | 91.76% | +1.75 pp |
| 2019 | 2019-12-31 | 90.01% | −0.62 pp |
| 2018 | 2018-12-31 | 90.63% | +2.58 pp |
| 2017 | 2017-12-31 | 88.05% | — |
| 2015 | 2015-12-31 | 100.00% | — |
Lexicon Pharmaceuticals quarterly gross margin
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q4.20
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 94.36% | −5.52 pp |
| Q1 2026 | 2026-03-31 | 99.49% | +1.87 pp |
| Q4 2025 | 2025-12-31 | 96.34% | +18.79 pp |
| Q3 2025 | 2025-09-30 | 99.93% | +4.01 pp |
| Q2 2025 | 2025-06-30 | 99.89% | +10.15 pp |
| Q1 2025 | 2025-03-31 | 97.62% | +0.46 pp |
| Q4 2024 | 2024-12-31 | 77.55% | −12.02 pp |
| Q3 2024 | 2024-09-30 | 95.92% | +0.65 pp |
| Q2 2024 | 2024-06-30 | 89.73% | −7.52 pp |
| Q1 2024 | 2024-03-31 | 97.16% | — |
| Q4 2023 | 2023-12-31 | 89.57% | — |
| Q3 2023 | 2023-09-30 | 95.27% | — |
| Q2 2023 | 2023-06-30 | 97.25% | — |
| Q4 2020 | 2020-12-31 | 100.00% | +3052.35 pp |
| Q2 2020 | 2020-06-30 | −2,812.00% | −2757.70 pp |
| Q1 2020 | 2020-03-31 | −7,000.00% | −7077.33 pp |
| Q4 2019 | 2019-12-31 | −2,952.35% | −2947.80 pp |
| Q3 2019 | 2019-09-30 | 99.80% | +98.90 pp |
| Q2 2019 | 2019-06-30 | −54.30% | −141.22 pp |
| Q1 2019 | 2019-03-31 | 77.33% | −19.99 pp |
| Q4 2018 | 2018-12-31 | −4.56% | +89.14 pp |
| Q3 2018 | 2018-09-30 | 0.90% | −96.26 pp |
| Q2 2018 | 2018-06-30 | 86.91% | −6.46 pp |
| Q1 2018 | 2018-03-31 | 97.31% | −1.43 pp |
| Q4 2017 | 2017-12-31 | −93.70% | +168.05 pp |
| Q3 2017 | 2017-09-30 | 97.16% | −2.84 pp |
| Q2 2017 | 2017-06-30 | 93.37% | −6.63 pp |
| Q1 2017 | 2017-03-31 | 98.75% | −1.25 pp |
| Q4 2016 | 2016-12-31 | −261.75% | — |
| Q3 2016 | 2016-09-30 | 100.00% | — |
| Q2 2016 | 2016-06-30 | 100.00% | — |
| Q1 2016 | 2016-03-31 | 100.00% | — |
Lexicon Pharmaceuticals gross margin trends
Over the last five fiscal years, Lexicon Pharmaceuticals's gross margin increased from 91.76% to 99.45%, a change of +7.69 percentage points. The latest reported quarter, Q2 2026, shows 94.36%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lexicon Pharmaceuticals source filings ↗